Recurrent Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Cabozantinib (DB08875)

IndicationStatusPhase
DBCOND0082715 (Recurrent Malignant Solid Neoplasm)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01822522Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusTreatment